BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

Aragen Bioscience and Getinge Validate Single-Use Production Reactors for Large-Scale Recombinant Antibody Production

Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish...

June 05, 2024 | News

HuidaGene Therapeutics and Synthego Corporation Forge Licensing Agreement for Advanced CRISPR Nuclease

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corpo...

May 31, 2024 | News

Takara Bio Inc. Launches Large-Scale Viral Vector Manufacturing with Thermo Fisher’s DynaDrive Bioreactors

Thermo Fisher Scientific in Japan is pleased to announce that, as of 22 April 2024, Takara Bio Inc. has begun large-scale viral vector contract manufacturi...

May 30, 2024 | News

Cytiva Launches Sefia: Advanced Platform to Transform CAR T Cell Therapy Manufacturing

Sefia cell therapy manufacturing platform comes out of Cytiva's extensive R&D expertise and in-depth understanding of CAR T manufacturing Automation...

May 30, 2024 | News

Eli Lilly Doubles Investment in Indiana Manufacturing Site with New $5.3 Billion Commitment

Eli Lilly and Company announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 bi...

May 28, 2024 | News

Merck Acquires Mirus Bio for $600 Million to Strengthen Viral Vector Manufacturing Capabilities

Acquisition will advance Merck’s integrated offering for viral vector manufacturing Complements existing portfolio for development and production ...

May 23, 2024 | News

Touchlight Genetics and NPL Receive Innovate UK Funding for Advanced Gene Therapy Technology

Touchlight Genetics, in partnership with the National Physical Laboratory (NPL) have secured funding from Innovate UK under their Innovative Technologies: ...

May 13, 2024 | News

Ribobay Pharma Partners with Cytiva to Launch Pioneering Oligonucleotide Manufacturing Platform in China

Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of Genera...

May 09, 2024 | News

WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services

First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...

April 30, 2024 | Company results

AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies

AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...

April 25, 2024 | News

AGC Biologics Expands in Yokohama with Advanced Biomanufacturing Hub Featuring Cytiva Technology

New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy ser...

April 23, 2024 | News

WuXi AppTec's Changzhou Facility Gains PMDA Approval, Bolstering Global Expansion Plans

Latest regulatory approval follows on the back of expansion plans announced during DCAT 2024 With peptides, oligos and peptide conjugates continui...

April 22, 2024 | News

Merck Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing

Proprietary Aptegra™ platform reduces five assays to one Results in 66% faster testing time and significantly lower cost for clients compared to t...

April 17, 2024 | News

Bloomage Secures Global Trust with Comprehensive Compliance, Passing Japan's PMDA Audit and Other International Inspections

Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted by Japan's Pharmaceuticals and M...

April 16, 2024 | Regulatory

Stay Connected